INTRAOPERATIVE BLOOD-TRANSFUSION IS A MAJOR RISK FACTOR FOR CORONARY-ARTERY BYPASS-GRAFTING IN WOMEN

被引:36
作者
UTLEY, JR [1 ]
WILDE, EF [1 ]
LEYLAND, SA [1 ]
MORGAN, MS [1 ]
JOHNSON, HD [1 ]
机构
[1] SPARTANBURG REG MED CTR,DIV CARDIAC SURG,SPARTANBURG,SC
关键词
D O I
10.1016/0003-4975(95)00416-I
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Women have been found to have greater mortality from coronary artery bypass grafting than men. Uncertainty exists regarding the causes of the differences in outcomes between men and women after coronary artery bypass grafting. Methods. From a database of 2,569 patients having coronary bypass grafting we have determined factors that contribute to poorer outcomes in women compared with men. Results. Women were found to have greater mortality, postoperative bleeding, and postoperative pulmonary failure than men (p < 0.05). There was no significant difference between men and women in postoperative renal failure, postoperative infection, postoperative stroke, or intraaortic balloon pump (p = not significant). Patient factors other than sex accounted for all the significant predictors (stepwise logistic regression) of mortality, postoperative bleeding, postoperative renal failure, postoperative pulmonary failure, postoperative stroke, need for intraaortic balloon pump, and postoperative infection (p < 0.05). Poorer outcomes in women are associated with greater need for transfusion during operation. Diabetes is predictive of renal failure and stroke. Conclusions. Mortality and morbidity is less in men despite their higher preoperative creatinine level, greater incidence of reoperation, lower ejection fraction, and more common atherosclerosis of the ascending aorta.
引用
收藏
页码:570 / 574
页数:5
相关论文
共 25 条
[1]   DIFFERENCES IN THE USE OF PROCEDURES BETWEEN WOMEN AND MEN HOSPITALIZED FOR CORONARY HEART-DISEASE [J].
AYANIAN, JZ ;
EPSTEIN, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (04) :221-225
[2]   CORONARY-ARTERY BYPASS-SURGERY IN WOMEN [J].
BECKER, RC ;
CORRAO, JM ;
ALPERT, JS .
CLINICAL CARDIOLOGY, 1988, 11 (07) :443-448
[3]  
BOLOOKI H, 1975, J THORAC CARDIOV SUR, V69, P271
[4]   A PLATELET-INHIBITOR-DRUG TRIAL IN CORONARY-ARTERY BYPASS OPERATIONS - BENEFIT OF PERIOPERATIVE DIPYRIDAMOLE AND ASPIRIN THERAPY ON EARLY POSTOPERATIVE VEIN-GRAFT PATENCY [J].
CHESEBRO, JH ;
CLEMENTS, IP ;
FUSTER, V ;
ELVEBACK, LR ;
SMITH, HC ;
BARDSLEY, WT ;
FRYE, RL ;
HOLMES, DR ;
VLIETSTRA, RE ;
PLUTH, JR ;
WALLACE, RB ;
PUGA, FJ ;
ORSZULAK, TA ;
PIEHLER, JM ;
SCHAFF, HV ;
DANIELSON, GK .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (02) :73-78
[5]  
Cooper John R. Jr., 1993, P124
[6]  
DOUGLAS JS, 1981, CIRCULATION, V64, P11
[7]  
FISHER LD, 1982, J THORAC CARDIOV SUR, V84, P334
[8]  
FRANKEL HM, 1986, JAMA-J AM MED ASSOC, V255, P125
[9]   CORONARY-ARTERY BYPASS-GRAFTING IN WOMEN - A 10-YEAR PERSPECTIVE [J].
GARDNER, TJ ;
HORNEFFER, PJ ;
GOTT, VL ;
WATKINS, L ;
BAUMGARTNER, WA ;
BORKON, AM ;
REITZ, BA .
ANNALS OF SURGERY, 1985, 201 (06) :780-784
[10]  
GOLDING L R, 1976, Cleveland Clinic Quarterly, V43, P113